Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

Gainers

Senti Biosciences, Inc. (NASDAQ:SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China.

Tharimmune, Inc. (NASDAQ:THAR) shares rose 76.8% to $0.2790 in pre-market trading as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.

TransMedics Group, Inc. (NASDAQ:TMDX) shares rose 39.7% to $56.16 in pre-market trading after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance.

GSE Systems, Inc. (NASDAQ:GVP) rose 18.3% to $3.88 in pre-market trading. GSE Solutions was recently awarded a $4.2 million contract from a large utility for nuclear power plant engineering work.

Unisys Corporation (NYSE:UIS) shares climbed 17.7% to $3.40 in pre-market trading after the company posted upbeat third-quarter results and raised the FY23 revenue growth forecast.

Alteryx, Inc. (NYSE:AYX) shares jumped 16.3% to $35.28 in pre-market trading after reporting better-than-expected third-quarter financial results.

Augmedix, Inc. (NASDAQ:AUGX) shares rose 15% to $5.23 in pre-market trading following strong third-quarter results.

Color Star Technology Co., Ltd. (NASDAQ:ADD) rose 14.9% to $0.3802 in pre-market trading after gaining around 44% on Monday.

CF Acquisition Corp. IV (NASDAQ:CFIV) gained 11.2% to $11.89 in pre-market trading.

Tripadvisor, Inc. (NASDAQ:TRIP) shares rose 11% to $17.88 in pre-market trading after the company reported better-than-expected third-quarter financial results.

Losers

Ventyx Biosciences, Inc. (NASDAQ:VTYX) dipped 74% to $3.66 in pre-market trading after the company announced efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target to support further development of VTX958 in psoriasis.

Alto Ingredients, Inc. (NASDAQ:ALTO) shares fell 52.4% to $2.34 in pre-market trading after the company reported mixed third-quarter financial results.

MSP Recovery, Inc. (NASDAQ:LIFW) shares fell 24.4% to $7.30 in pre-market trading after jumping 252% on Monday.

Coherus BioSciences, Inc. (NASDAQ:CHRS) shares fell 18.9% to $2.87 in pre-market trading after the company reported mixed third-quarter financial results.

Ameresco, Inc. (NASDAQ:AMRC) shares fell 18.4% to $21.70 in pre-market trading following downbeat third-quarter results.

Aura Biosciences, Inc. (NASDAQ:AURA) fell 15.5% to $9.30 in pre-market. Aura Biosciences priced its public offering of 11 million common shares at $9 per share.

Clover Health Investments, Corp. (NASDAQ:CLOV) shares fell 15.1% to $0.96 in pre-market trading following weak quarterly sales.

Trevena, Inc. (NASDAQ:TRVN) shares fell 11.2% to $0.5139 in pre-market trading.

Tenon Medical, Inc. (NASDAQ:TNON) fell 11% to $1.78 in pre-market trading after jumping 57% on Monday. Tenon Medical recently announced it passed an FDA Level 2 Inspection.

NanoString Technologies, Inc. (NASDAQ:NSTG) fell 9.4% to $1.25 in pre-market trading after the company posted third-quarter results and narrowed its FY23 revenue guidance.

Now Read This: Amazon, Walmart And 2 Other Stocks Insiders Are Selling